Coverage rate of opportunistic and organised breast cancer screening in France: Department-level estimation

Defossez, 2019, Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018, Vol. 1 – Tumeurs Solides St. (Fra): Sante Publique Fr., 372 Ministry of Health and Solidarity. Order of 29 September 2006 on cancer screening programmes [Internet]. 2006 [cited 8 Nov 2017]. p. 48. Available at: 〈https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000460656〉. Santé publique France. Taux de participation au programme de dépistage organisé du cancer du sein. Available at: https://www.santepubliquefrance.fr/maladies-et-traumatismes/cancers/cancer-du-sein/articles/taux-de-participation-au-programme-de-depistage-organise-du-cancer-du-sein-2020-2021-et-evolution-depuis-2005. Hirtzlin, 2012, Dépistage individuel du cancer du sein des femmes de 50 à 74 ans en France en 2009. Numéro thématique. Dépistage organisé du cancer du sein, Bull. Epidemiol. Hebd., 35–36–37, 410 Duport, 2012, Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey, Rev. Epidemiol. Sante Publique, 60, 421, 10.1016/j.respe.2012.05.006 Ouédraogo, 2014, Breast cancer screening programmes: challenging the coexistence with opportunistic mammography, Patient Educ. Couns., 97, 410, 10.1016/j.pec.2014.08.016 Quintin, 2018, 48 Tuppin, 2017, Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France, Rev. Epidemiol. Sante Publique, 65, S149, 10.1016/j.respe.2017.05.004 INSEE: 〈https://www.insee.fr/fr/information/2008354〉. Uhry Z., Remontet L., Colonna M., Belot A., Grosclaude P., Mitton N., et al. Estimation départementale de l’incidence des cancers à partir des données d’affection de longue durée (ALD) et des registres. Evaluation par localisation cancéreuse, 2000–2005 Rapport institut de veille sanitaire, Janvier (2012). Lailler, 2021, Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data, Clin. Breast Cancer, 21, e415, 10.1016/j.clbc.2021.01.007 Khelifa A., Verzaux L. L’utilisation de Senolog dans l’évaluation du taux reél de couverture du dépistage du cancer du sein. Le médecin radiologue n°378, mars 2015. L’équipe Senolog. Senolog – analyse des données collectées en 2016. Le médecin radiologue n°406, octobre 2017. Ouédraogo, 2015, Dépistage du cancer du sein dans treize départements français [Breast cancer screening in thirteen French departments], Bull. Cancer, 102, 126, 10.1016/j.bulcan.2014.07.002 Zielonke, 2021, The potential of breast cancer screening in Europe, Int. J. Cancer, 148, 406, 10.1002/ijc.33204 Goossens, 2019, Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016), BMC Cancer, 19, 1012, 10.1186/s12885-019-6230-z Menvielle, 2018, Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies, Eur. J. Cancer Prev., 27, 269, 10.1097/CEJ.0000000000000329 Menvielle, 2014, To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010, Cancer Causes Control., 25, 977, 10.1007/s10552-014-0397-z Rauscher, 2008, Accuracy of self-reported cancer-screening histories: a meta-analysis, Cancer Epidemiol. Biomark. Prev., 17, 748, 10.1158/1055-9965.EPI-07-2629 Howard, 2009, Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis, Cancer Causes Control, 20, 1, 10.1007/s10552-008-9228-4 European Commission, 2006, 416 Kalecinski, 2015, Dépistage organisé ou individuel du cancer du sein ? attitudes et représentations des femmes [Organized or individual breast cancer screening: what motivates women?], Sante Publique, 27, 213, 10.3917/spub.152.0213 Guillaume, 2017, Could mobile mammography reduce social and geographic inequalities in breast cancer screening participation?, Prev. Med., 100, 84, 10.1016/j.ypmed.2017.04.006 Ouédraogo, 2014, European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France, Prev. Med., 63, 103, 10.1016/j.ypmed.2013.12.007 Pornet, 2010, Socioeconomic and healthcare supply statistical determinants of compliance to mammography screening programs: a multilevel analysis in Calvados, France, Cancer Epidemiol., 34, 309, 10.1016/j.canep.2010.03.010 Deborde, 2018, Breast cancer screening programme participation and socioeconomic deprivation in France, Prev. Med., 115, 53, 10.1016/j.ypmed.2018.08.006 Eisinger, 2017, Dépistage du cancer en France: 10 ans d’analyse des comportements par les enquêtes EDIFICE [Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys], Bull. Cancer, 104, 258, 10.1016/j.bulcan.2016.12.002 Ferrat, 2013, Understanding barriers to organized breast cancer screening in France: women’s perceptions, attitudes, and knowledge, Fam. Pract., 30, 445, 10.1093/fampra/cmt004 F.Lançon, N.Sannino, J.Viguier. Connaissances, perceptions, attitudes et comportements des femmes et des médecins vis-à-vis du dépistage du cancer du sein, France, 2010, BEH, 2012. Institut National du Cancer: 〈https://www.e-cancer.fr/Institut-national-du-cancer/Democratie-sanitaire/Concertation-citoyenne-sur-le-depistage-du-cancer-du-sein〉.